With political pressure rising and the midterm elections approaching, a top drug industry trade group has set another record for lobbying spending in Washington.
The Pharmaceutical Research and Manufacturers of America spent $15.5 million lobbying the federal government in the first half of this year. That’s the most PhRMA has spent in a comparable six-month period since at least 2001, the earliest year online records are available, according to lobbying disclosure filings updated on Friday.
Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
